Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression.

Euler Z, van Gils MJ, Bunnik EM, Phung P, Schweighardt B, Wrin T, Schuitemaker H.

J Infect Dis. 2010 Apr 1;201(7):1045-53. doi: 10.1086/651144.

PMID:
20170371
2.

Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression.

van Gils MJ, Euler Z, Schweighardt B, Wrin T, Schuitemaker H.

AIDS. 2009 Nov 27;23(18):2405-14. doi: 10.1097/QAD.0b013e32833243e7.

PMID:
19770692
3.
5.

Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection.

Carotenuto P, Looij D, Keldermans L, de Wolf F, Goudsmit J.

AIDS. 1998 Sep 10;12(13):1591-600.

PMID:
9764777
6.

Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.

Hu X, Hong K, Zhao C, Zheng Y, Ma L, Ruan Y, Gao H, Greene K, Sarzotti-Kelsoe M, Montefiori DC, Shao Y.

J Gen Virol. 2012 Oct;93(Pt 10):2267-78. doi: 10.1099/vir.0.043802-0. Epub 2012 Jul 12.

PMID:
22791603
7.

Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.

Hogervorst E, Jurriaans S, de Wolf F, van Wijk A, Wiersma A, Valk M, Roos M, van Gemen B, Coutinho R, Miedema F, et al.

J Infect Dis. 1995 Apr;171(4):811-21.

PMID:
7706807
8.
9.

Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals.

Euler Z, van Gils MJ, Boeser-Nunnink BD, Schuitemaker H, van Manen D.

PLoS One. 2013;8(1):e54684. doi: 10.1371/journal.pone.0054684. Epub 2013 Jan 23.

10.

Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.

Spijkerman IJ, Prins M, Goudsmit J, Veugelers PJ, Coutinho RA, Miedema F, de Wolf F.

AIDS. 1997 Sep;11(11):1383-8.

PMID:
9302449
11.

Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease.

Keet IP, Krol A, Koot M, Roos MT, de Wolf F, Miedema F, Coutinho RA.

AIDS. 1994 Nov;8(11):1577-83.

PMID:
7848594
12.

Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.

Furrer H, Barloggio A, Egger M, Garweg JG; Swiss HIV Cohort Study.

Ophthalmology. 2003 Feb;110(2):432-6.

PMID:
12578793
13.

Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Sánchez-Ramón S, Bellón JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT, Muñoz-Fernández MA.

Pediatrics. 2003 Feb;111(2):E168-75.

PMID:
12563091
14.

Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.

Jennes W, Camara M, Dièye T, Mboup S, Kestens L.

J Virol. 2008 Sep;82(17):8619-28. doi: 10.1128/JVI.00027-08. Epub 2008 Jun 18.

15.

Specificities of broadly neutralizing anti-HIV-1 sera.

Binley J.

Curr Opin HIV AIDS. 2009 Sep;4(5):364-72. doi: 10.1097/COH.0b013e32832e06fe. Review.

PMID:
20048699
16.

Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.

Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J.

AIDS. 1996 Feb;10(2):167-73.

PMID:
8838704
17.

Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.

Mascola JR, Lewis MG, VanCott TC, Stiegler G, Katinger H, Seaman M, Beaudry K, Barouch DH, Korioth-Schmitz B, Krivulka G, Sambor A, Welcher B, Douek DC, Montefiori DC, Shiver JW, Poignard P, Burton DR, Letvin NL.

J Virol. 2003 Oct;77(19):10348-56.

19.
20.

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Mellors JW, Muñoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, Kingsley LA, Todd JA, Saah AJ, Detels R, Phair JP, Rinaldo CR Jr.

Ann Intern Med. 1997 Jun 15;126(12):946-54.

PMID:
9182471

Supplemental Content

Support Center